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A proposal for a new design: the exposureecrossover designMcClure [1] has commented that differences between
operational hypotheses such as ‘why me?’ versus ‘why
now?’ should be tested by case-control versus case-
crossover studies. Redelmeier extends this to propose that
whereas a randomized trial asks ‘‘Does assigning an expo-
sure lead to average differences?,’’ a new design (the ‘expo-
sureecrossover design’) asks ‘‘Does receiving an exposure
lead to individual changes?’’ Using issues relating to motor
vehicle accidents, he argues that this new design be used to
test hypotheses such as: (a) that a motor vehicle crash might
alter the subsequent risk of a motor vehicle crash of a pa-
tient; and (b) that becoming a mother of a newborn might
change the subsequent risk of a motor vehicle crash of a pa-
tient. With large databases increasingly available, such
questions can now be addressed with such a design. This
was possible in these cases by having access to a database
containing the records of all patients who had a motor ve-
hicle incident in Ontario, Canada over a 5-year accrual in-
terval, with time-zero defined as the date of the crash in
which the patient was the driver. Each patient was then ob-
served for 5 years (4 years before time-zero and 1 year after
time-zero), forming multiple segments of 28-day duration.
The outcome was whether the patient was a driver in a mo-
tor vehicle crash. This is one type of the interrupted time
series design that itself is a one example of the Regression
Discontinuity designs that, although popular in areas such
as education and development economics [2], are less com-
mon in health. These are likely to be more common as more
large databases come on line [3,4]. In another manuscript
on large databases, in this case capitalizing on the linkage
of population-based prescription databases and birth regis-
tries in the five Nordic countries (Denmark, Finland, Ice-
land, Norway, and Sweden) to study rare outcomes and
exposure (such as the effects of prescription drug use in
pregnancy). Skurtveit et al used these to assess the impact
of exposure misclassification on risk associations when us-
ing prescription databases as the source for drug exposure
in pregnancy by applying results from a validation analysis
of exposure classification. Although initially counterintui-
tive, but logical once thought through, they found that in-
cluding expansion of the time window to include intervals
before pregnancy can lead to lower specificity and underes-
timation of risk associations.
Hartling et al publish two papers this month. In the first
paper they sought to assess the reliability of the Cochrane
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found that low agreement has implications for interpreting
systematic reviews. Reliability was influenced by study-
level variables, including the nature of the outcome, nature
of the intervention, study design, trial hypothesis, and fund-
ing source. Variability resulted more often from different
interpretation of the tool rather than different information
identified in the study reports. These findings provide direc-
tion for more detailed guidance in applying the ROB tool.
A second paper sought to assess the inter-rater reliability
and validity of the Newcastle Ottawa Scale (NOS) used
for methodological quality assessment of cohort studies in-
cluded in systematic reviews; the findings of this study un-
derscore the need for revisions and more detailed guidance
to apply the NOS in systematic reviews.
The powerful social movement in many countries toward
patient-oriented/patient-centered/patient-driven research is
leading to a surge in developing and testing out different
mixed-methods approaches to tackle different practice and
policy-relevant topics. In this issue, Busija et al used
a mixed-methods approach to develop a conceptual model
to describe the personal burden of osteoarthritis, as well as
an extended version that describes the societal burden on
the broader community.
The importance of patient adherence to treatment once
efficacy is established in chronic disease has been brought
to the fore in clinical epidemiology by Haynes et al [5].
HIV treatment programs are now judged by their ‘LTFU’
(loss to follow-up) statistic. However, there is an urgent
need to international consensus of the definition of LTFU.
In a study of 8 different public sector program sites in
South Africa, Grimsrud et al found that the estimates could
vary by as much as 39% depending on the definition used.
These definitions varied by whether a patient who initiates
therapy but is not seen again are included, the time since
the patient was last seen, whether patients who died were
removed from the denominator, and ensuring the database
was not analyzed before the defined time of the analysis.
The authors propose a standard definition that at first glance
seems complicated but is clear when the manuscript is read.
Consensus on this topic urgently needs to be established.
Missing data from patients lost to follow-up is one of the
banes of clinical epidemiology; a survey of RCTs published
in prestigious general medical journals found that the dif-
ferent strategies currently used can change the interpreta-
tion of results in up to 33% of the RCTs studied [6]; this
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tematic reviews. Although the Cochrane handbook describes
strategies for handling this for dichotomous outcomes, this
has not been done for continuous outcomes. Ebrahim and
co-workers proposed a range of strategies and provide use-
ful, reasonable, and relatively simple quantitative guidance.
They demonstrate this with two systematic reviews. One
looks at the results of the Beck Depression Inventory score
following cognitive behavioral therapy and the other looking
at number of hairs in a specified area of the scalp after taking
finasteride.
Statistics.Within the field of longitudinal data analysis,
there is a debate raging about whether it is necessary to
use multiple imputations before performing a mixed-
model analysis to analyze the longitudinal data. Twisk
et al evaluate this theory and conclude that it is not neces-
sary to handle missing data using multiple imputations be-
fore performing a mixed-model analysis on longitudinal
data. Propensity score methods are frequently applied to
multicenter data. Gayat et al note that, to date, methods
for handling cluster effect when analyzing propensity
score-matched data have not been assessed for survival data.
The authors compared 5 strategies. One strategy analyzed
the original sample and four used global or within-cluster
matching using a global or a cluster-specific propensity
score. All were applied to simulated data sets and to 2 co-
horts. In the considered simulation scenarios, within-
cluster matching using a global propensity score presented
the best balance between sample size and bias reduction,
and it should be used when applying propensity-score
methods to clustered observational survival data. When es-
timating the number needed to treat (NNT) from RCTs with
time-to-event outcomes, varying follow-up times have to be
considered. Two methods have been proposed, namely (1)
inverting risk differences estimated by survival time
methods, and (2) inverting incidence differences. Bender
and co-workers conducted a simulation study to compare
these 2 approaches regarding bias and coverage probability.
In addition, the 2 approaches were compared by using 2 real
data examples from trials of adjuvant therapy; 1 in bladder
cancer with a mean follow-up of 13 months, and another in
colon cancer with a mean follow-up of over 5 years. They
found that inverting risk differences approach showed good
estimation and coverage properties with only a few excep-
tions in the case of small sample sizes and small effect sizes,
while the inverting incidence differences approach showed
considerable bias and low coverage probability in most of
the considered data situations. Statistical rules for eliminat-
ing redundant items to reduce the length of a questionnaire
from 65 to 30 items is reported in a study by Latour and col-
leagues to address concerns that the time to complete a val-
idated questionnaire the EMpowerment of PArents in THe
Intensive Care (EMPATHIC) questionnaire, which aims tomeasure the satisfaction of parents whose child has been ad-
mitted to pediatric intensive care units.
A number of articles look at issues around bias of differ-
ent types. Differential attrition is regarded as a major threat
to the internal validity of a randomized controlled trial
(RCT). Crutzen and colleagues, however, found that differ-
ential attrition did not generally occur in RCTs covering
a broad spectrum of clinical areas within general and inter-
nal medicine. In a commentary, Smulders discusses the
phenomena wherein ‘positive’ studies have a much larger
chance of acceptance after editorial and peer review than
‘negative’ ones. He opens the debate on whether it is pos-
sible to implement an editorial and peer-review procedure
that is blinded to study outcomes.
Beckles et al aimed to quantify the unique useful yield
from the Cumulative Index to Nursing and Allied Health
Literature (CINAHL) database to National Institute for
Health and Clinical Excellence (NICE) clinical guidelines.
It was hypothesized that the unique useful yield from CI-
NAHL is low, and this database can therefore be relegated
to selective rather than routine searching. The authors
found that the very low proportion of references unique
to CINAHL strongly suggests that this database can be
safely relegated to selective rather than routine searching;
however it should be used if a nursing topic is being
searched.
In the fifth installment of the monthly series on effective
writing and publishing of scientific papers, Kotz and Cals
discuss the writing of the results section of a paper.
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